>北美家庭检测试剂盒市场，按检测类型（妊娠检测、艾滋病毒检测试剂盒、糖尿病、传染病、葡萄糖检测、排卵预测检测试剂盒、药物滥用检测试剂盒等）、类型（盒式、试纸、中游、测试面板、浸卡等）、年龄（儿童、成人和老年人）、样品类型（尿液、血液、唾液和其他样品类型）、用途（一次性和可重复使用）、分销渠道（零售药店、药店、超市/大卖场和网上药店）划分 - 行业趋势和预测到 2029 年。
北美家庭检测试剂盒市场分析与洞察
北美家庭检测试剂盒市场预计将增长，因为以前人们经常去医院，即使是基本问题，但由于对多种产品的认识不断提高，这种行为已经改变并扭转了趋势。家庭或自测试剂盒在药店很容易买到，而且采购起来也变得非常容易。各种医疗公司都在进军这一领域，因为它们可以快速生产自测试剂盒。
这种广泛可用性也可以归功于在线药店的医疗初创企业，只需单击按钮即可轻松获得。此外，这些自检试剂盒无需处方即可获得，这很容易推动家用检测试剂盒市场的发展。家用检测试剂盒允许最终用户在家中收集样本，然后在家进行测试或将样本送到实验室进行测试。家用检测试剂盒无疑简化了确认个人担忧的过程，无论是家庭妊娠测试还是 HIV 或任何其他传染病测试。
这些家用检测试剂盒使用方便，价格也实惠。然而，人们对检测结果的准确性始终心存疑虑，这已成为北美家用检测试剂盒市场发展的制约因素。即使没有接受检测，假阳性结果也可能导致患者焦虑和压力。收到假阳性或假阴性结果会让人非常沮丧和不安。如今，许多公司生产 COVID-19 快速诊断检测试剂盒，可在家中进行检测。但由于存在各种与准确性相关的问题，这些家用检测试剂盒的分发已被暂停，无法验证其可靠性。
Data Bridge Market Research 分析称，2022 年至 2029 年的预测期内，北美家用检测试剂盒市场将以 6.3% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020 (可定制至 2019-2014) |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按测试类型（妊娠测试、艾滋病毒测试套件、糖尿病、传染病、葡萄糖测试、排卵预测测试套件、药物滥用测试套件等）、类型（盒式、试纸、中段、测试板、浸卡等）、年龄（儿童、成人和老年人）、样本类型（尿液、血液、唾液和其他样本类型）、用途（一次性和可重复使用）、分销渠道（零售药店、药店、超市/大卖场和网上药店） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
Abbott、Siemens Healthcare GmbH、F. Hoffmann-La Roche Ltd、BD、Drägerwerk AG & Co. KGaA、LifeScan IP Holdings, LLC、Ascensia Diabetes Care Holdings AG.、Nectar Lifesciences Ltd. (Rapikit)、ACON Laboratories, Inc.、Quidel Corporation.、ARKRAY USA, Inc.、BTNX INC.、Atomo Diagnostics、Eurofins Scientific、Piramal Enterprises Ltd.、Bionime Corporation.、Nova Biomedical、Cardinal Health.、OraSure Technologies、Biolytical Laboratories Inc.、Everlywell, Inc.、SA Scientific Ltd.、Clearblue（Swiss Precision Diagnostics GmbH 的子公司）、Biosynex、PRIMA Lab SA、MP BIOMEDICALS.、Sterilab Services、Chembio Diagnostics, Inc.、BioSure、Selfdiagnostics OU 等 |
北美家庭检测试剂盒市场定义
家用检测试剂盒是指可以帮助人们在家中进行检测并在一分钟内快速得出结果的检测仪器。它还包括健康监测设备，用于持续检查和控制糖尿病患者的健康状况。家用检测非常方便，可以舒适地在家中进行，而且价格非常实惠。自测通常是快速即时检测试剂盒的升级版，这种试剂盒最初是为医疗保健专业人员设计的，普通人也可以操作。它们的流程、包装和说明都已简化，以指导人们完成检测步骤。市面上有各种家用检测试剂盒，包括 HIV 检测、妊娠测试、糖尿病、排卵测试、疟疾、COVID-19 等传染病。为了进行这些快速的家用测试，可以抽取血液、尿液和口腔液体作为样本。
北美家庭检测试剂盒市场动态
驱动程序
- 自检试剂盒的采用率不断提高
以前，人们经常去医院，即使是一些基本问题。然而，随着人们对多种产品的认识不断提高，这种行为已经改变，并扭转了趋势。如今，人们更喜欢在去看医生之前先在家里用检测试剂盒做基本的检测。
由于疫情的影响，由于存在多项限制，人们开始采用更多自助检测试剂盒，这一点变得更加突出。这对医院和患者来说都是变相的福音，因为医院已经捉襟见肘，可以完全专注于 COVID-19 患者，而患者可以节省大量的看病和药费。这对消费者来说非常方便，因为他们可以快速知道他们的测试结果。
- 药店可轻松获得自测试剂盒
家用或自测试剂盒在药店很容易买到，而且采购起来也变得毫不费力。各大医疗公司纷纷涉足这一领域，快速生产自测试剂盒。
这种广泛普及也归功于网上药店的医疗初创企业，只需点击按钮即可轻松获得。此外，这些自测试剂盒无需处方即可获得。
机会
- 先进技术的出现
最新技术对于使医疗产品非常先进和可靠至关重要。在不同的医疗设备中，人工智能 (AI) 和机器学习 (ML) 是医疗保健领域的重要方面，能够通过工作自动化和更快的性能来增强患者安全性和管理流程。
可以肯定的是，人工智能诊断仪器将继续发展。人工智能在医疗保健领域的巨大而多维度的机遇中才刚刚迈出第一步。
克制/挑战
- 自检试剂盒结果不准确
家用检测试剂盒允许最终用户在家中收集样本并在家中进行检测或将样本送往实验室进行检测。家用检测试剂盒无疑简化了确认个人担忧的过程，无论是家庭妊娠检测、艾滋病毒检测还是任何其他传染病检测。
这些家用检测试剂盒使用方便，价格也实惠。然而，人们总是对结果的准确性存有疑虑。在家中监测 COVID-19 比去医院或医生办公室更舒服。它还有助于降低筛查时传播或感染冠状病毒的风险。
然而，假阳性检测结果可能会给患者带来焦虑和压力，即使患者没有接受检测。收到假阳性或阴性结果会让人非常沮丧和不安。如今，许多公司生产可在家中进行的 COVID-19 快速诊断检测试剂盒，但由于存在各种准确性相关问题，这些家用检测试剂盒的分发已被暂停，无法验证其可靠性。
COVID-19 对北美家庭检测试剂盒市场的影响
COVID-19 对家用检测试剂盒市场产生了巨大影响。由于自助和 DIY 检测试剂盒因其方便和快速的结果而越来越受欢迎，家用检测试剂盒市场正在扩大。消费者担心快速家用检测试剂盒的可靠性，这可能会阻碍家用检测试剂盒市场的扩张。现在，公司迫切需要 COVID-19 快速检测试剂盒，以减少患者死亡，提高患者康复率，并提高糖尿病患者和心脏病患者的家用检测试剂盒市场的比率。这为家用检测试剂盒创造了一个巨大的市场机会。
近期发展
- 2022 年 3 月，LifeScan IP Holdings, LLC 宣布，该公司的产品 OneTouch Verio Flex 凭借价格、实惠的试纸、颜色范围指示器、少量血液样本和紧凑的设计荣登《福布斯健康》最佳标准血糖仪榜首。这有助于该公司提高其在全球市场的影响力
北美家庭检测试剂盒市场范围
北美家庭检测试剂盒市场根据检测类型、类型、年龄、样本类型、用途和分销渠道分为六个值得注意的细分市场。这些细分市场之间的增长将帮助您分析行业中的市场增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
测试类型
- 妊娠试验
- HIV 检测试剂盒
- 糖尿病
- 传染病
- 葡萄糖测试
- 排卵预测测试套件
- 药物滥用检测试剂盒
- 其他的
根据测试类型，北美家用检测试剂盒市场分为妊娠测试、艾滋病毒检测试剂盒、糖尿病、传染病、葡萄糖测试、排卵预测检测试剂盒、药物滥用检测试剂盒等。
类型
- 卡式磁带
- 条
- 中游
- 测试面板
- 浸卡
- 其他的
根据类型，北美家庭测试套件市场分为盒式、条式、中游、测试面板、浸卡和其他。
年龄
- 儿科
- 成人
- 老年
根据年龄，北美家庭检测试剂盒市场分为儿童、成人和老年人。
样品类型
- 尿
- 血
- 唾液
- 其他的
根据样本类型，北美家庭检测试剂盒市场分为尿液、血液、唾液和其他。
用法
- 一次性的
- 可重复使用的
根据用途，北美家庭检测试剂盒市场分为一次性和可重复使用。
分销渠道
- 零售药店
- 药店
- 超市/大卖场
- 网上药店
根据分销渠道，北美家庭检测试剂盒市场分为零售药店、药店、超市/大卖场和在线药店。
北美家庭检测试剂盒市场区域分析/见解
对北美家庭检测试剂盒市场进行分析，并根据测试类型、类型、年龄、样本类型、用途和分销渠道提供市场规模洞察和趋势。
北美家庭检测试剂盒市场报告涵盖的地区包括美国、加拿大和墨西哥。
在市场份额和市场收入方面，美国在北美家用检测试剂盒市场占据主导地位，并将在预测期内继续保持主导地位。这是由于该国医疗保健支出高昂，以及人们对北美家用检测试剂盒市场的认识不断提高。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
竞争格局和北美家庭检测试剂盒市场份额分析
北美家用检测试剂盒市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对北美家用检测试剂盒市场的关注有关。
北美家用检测试剂盒市场的一些主要参与者包括雅培 (Abbott)、ACON Laboratories, Inc.、Rapikit、BD、Cardinal Health、B. Braun Melsungen AG、Piramal Enterprises Ltd.、西门子医疗有限公司 (Siemens Healthcare GmbH)、Quidel Corporation、Bionime Corporation、SA Scientific、ARKRAY USA, Inc.、Nova Biomedical、AdvaCare Pharma、AccuBioTech Co., Ltd.、Atlas Medical UK、TaiDoc Technology Corporation、Drägerwerk AG & Co. KGaA、F. Hoffmann-La Roche Ltd、Sensing Self, PTE. Ltd、Atomo Diagnostics、RUNBIO BIOTECH CO.,LTD.、Mylan NV (Viatris, Inc. 的子公司)、MP BIOMEDICALS、VedaLab、上海 Chemtron Biotech Co.Ltd. 和 Ascensia Diabetes Care Holdings AG 等国内参与者。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA AT-HOME TESTING KITS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
2.8 MARKET POSITION COVERAGE GRID
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.11 DISTRIBUTOR CHANNEL ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 NORTH AMERICA AT- HOME TESTING KITS MARKET: REGULATIONS
5.1 REGULATION IN U.S
5.2 GUIDELINES FOR SELF-TESTING KITS
5.3 REGULATION IN EUROPE
5.4 GUIDELINES FOR TESTING KITS
5.5 REGULATION IN INDONESIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS
6.2 RESTRAINTS
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS
6.3 OPPORTUNITIES
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS
6.4 CHALLENGES
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS
7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 GLUCOSE TESTS
7.3 INFECTIOUS DISEASES
7.4 PREGNANCY TEST
7.5 DRUG ABUSE TEST KITS
7.6 HIV TEST KIT
7.7 OVULATION PREDICTOR TEST KIT
7.8 OTHERS TEST TYPES
8 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE
8.1 OVERVIEW
8.2 CASSETTES
8.2.1 RETAIL PHARMACIES
8.2.2 ONLINE PHARMACIES
8.2.3 DRUG STORE
8.2.4 SUPERMARKET/HYPERMARKET
8.3 STRIP
8.3.1 RETAIL PHARMACIES
8.3.2 ONLINE PHARMACIES
8.3.3 DRUG STORE
8.3.4 SUPERMARKET/HYPERMARKET
8.4 MIDSTREAM
8.4.1 RETAIL PHARMACIES
8.4.2 ONLINE PHARMACIES
8.4.3 DRUG STORE
8.4.4 SUPERMARKET/HYPERMARKET
8.5 DIP CARD
8.5.1 RETAIL PHARMACIES
8.5.2 ONLINE PHARMACIES
8.5.3 DRUG STORE
8.5.4 SUPERMARKET/HYPERMARKET
8.6 TEST PANEL
8.6.1 RETAIL PHARMACIES
8.6.2 ONLINE PHARMACIES
8.6.3 DRUG STORE
8.6.4 SUPERMARKET/HYPERMARKET
8.7 OTHERS
9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE
9.1 OVERVIEW
9.2 ADULT
9.3 GERIATRIC
9.4 PEDIATRIC
10 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHER SAMPLE TYPES
11 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE
11.1 OVERVIEW
11.2 DISPOSABLE
11.3 REUSABLE
12 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS
12.1 OVERVIEW
12.2 RETAIL PHARMACIES
12.3 ONLINE PHARMACIES
12.4 DRUG STORE
12.5 SUPERMARKET/HYPERMARKET
13 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUS ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 SIEMENS HEALTHCARE GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUS ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 F. HOFFMANN- LA ROCHE LTD
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 BD
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 DRÄGERWERK AG & CO. KGAA
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 LIFESCAN IP HOLDINGS, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 COMPANY SHARE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 ASCENSIA DIABETES CARE HOLDINGS AG.
16.7.1 COMPANY SNAPSHOT
16.7.2 COMPANY SHARE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT)
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 ACON LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 QUIDEL CORPORATION.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 ARKRAY USA, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 BTNX INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 ATOMO DIAGNOSTICS
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 EUROFINS SCIENTIFIC
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS
16.15 PIRAMAL ENTERPRISES LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 BIONIME CORPORATION
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NOVA BIOMEDICAL
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 CARDINAL HEALTH.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 ORASURE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 BIOLYTICAL LABORATORIES INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 EVERLYWELL, INC.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SA SCIENTIFIC LTD.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 BIOSYNEX
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 PRIMA LAB SA
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
16.26 MP BIOMEDICALS.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 STERILAB SERVICES
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 CHEMBIO DIAGNOSTICS, INC.
16.28.1 COMPANY SNAPSHOT
16.28.2 REVENUE ANALYSIS
16.28.3 PRODUCT PORTFOLIO
16.28.4 RECENT DEVELOPMENTS
16.29 BIOSURE
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENTS
16.3 SELFDIAGNOSTICS OU
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA GLUCOSE TESTS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA OVULATION PREDICTOR TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS TEST TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA OTHERS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA ADULT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA BLOOD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA URINE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA SALIVA IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA OTHER SAMPLE TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA DISPOSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA REUSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA RETAIL PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 50 U.S. AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 51 U.S. AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 U.S. STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 53 U.S. CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 54 U.S. MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 55 U.S. DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 56 U.S. TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 57 U.S. AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 58 U.S. AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 59 U.S. AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 60 U.S. AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 61 CANADA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 62 CANADA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 63 CANADA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 64 CANADA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 65 CANADA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 66 CANADA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 67 CANADA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 68 CANADA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 69 CANADA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 70 CANADA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 71 CANADA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 72 MEXICO AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 73 MEXICO AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 MEXICO STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 75 MEXICO CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 76 MEXICO MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 77 MEXICO DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 78 MEXICO TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 79 MEXICO AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 80 MEXICO AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 81 MEXICO AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 82 MEXICO AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA AT-HOME TESTING KITS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID
FIGURE 7 NORTH AMERICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET: DISTRIBUTOR CHANNEL ANALYSIS
FIGURE 10 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 GLUCOSE TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS THE FASTEST GROWING REGION IN THE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA AT-HOME TESTING KITS MARKET
FIGURE 15 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021
FIGURE 16 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2021
FIGURE 20 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2021
FIGURE 24 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021
FIGURE 28 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022-2029 (EURO MILLION)
FIGURE 29 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 31 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2021
FIGURE 32 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2022-2029 (EURO MILLION)
FIGURE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 36 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 37 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET: SNAPSHOT (2021)
FIGURE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021)
FIGURE 41 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE (2022-2029)
FIGURE 44 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
